Clinical Trials Directory

Trials / Completed

CompletedNCT03947060

The Alternative Position for the SedLine® Sensor

BI-SENSES: Validation of Nasal Versus Frontal Placement of the SedLine® Sensor Through Processed Electroencephalography in Adult Patients Undergoing General Anesthesia

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Cleveland Clinic Abu Dhabi · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

SedLine® Brain Function Monitoring provides real-time insight into a patient's depth of anesthesia with bilateral data acquisition and processing of electroencephalogram (EEG) signals. Four active EEG leads collect data from the frontal lobe with a sensor position on the patient's forehead. Whenever a frontal approach for neurosurgical procedures is required or the frontal placement of the EEG is not indicated, it would not be possible to place the SedLine® . Numerous studies have analyzed the change of position and the application of alternative positions for other devices used in assessing the depth of anesthesia. Albeit, yet to date, there is no study that analyzed the application of alternative positions for the SedLine® sensor.

Detailed description

The purpose of study is to compare the standard forehead placement versus a nasal placement of SedLine® sensor for neuromonitoring. The hypothesis is that placing the central sensors in the montage approximately 2 cm below the standard recommended placement, across the nasal bridge and then running under the eyes to the normal temporal leads placement would put the entire montage out of the operative field and would still have corresponding values and EEG signals. The primary outcome measure is to monitor and compare processed electroencephalograph (EEG) values (PSi- Patient State Index, SEFL- Spectral Edge Frequency Left, SEFR- Spectral Edge Frequency Right, SR-Suppression Ratio, EMG-Electromyography, ARTF-Artifact) and EEG waveforms, on both sensors (standard-Forehead and alternative-Nasal) Other parameters that will be measure are patient demographics (age, sex, surgery, ASA status, weight, height, BMI).

Conditions

Timeline

Start date
2019-12-01
Primary completion
2020-02-29
Completion
2020-04-01
First posted
2019-05-13
Last updated
2020-07-15

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT03947060. Inclusion in this directory is not an endorsement.